The results showed that TTCS induced significantly more tumor‐infiltrating neutrophils to migrate than NTCS from the same GC patients, and such migration was blocked upon pre‐treatment with neutralizing antibodies against CXCL12 and/or CXCR4 (Figure 3E). This evidence concerns the gene CXCL12 and neoplasm.